FindTrial
Sign In

The significance of serum uric acid in acute stroke.

A clinical study of stroke with special emphasis on role of serum uric acid in acute ischemic stroke: A Prospective Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/08/035792
Enrollment
31
Registered
2021-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G969- Disorder of central nervous system, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

DR SAKSHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ACUTE ISCHEMIC STROKE WITH CT SCAN EVIDENCE OF INFARCTION WITHIN 72 HOUR OF ONSET OF STROKE.

Exclusion criteria

Exclusion criteria: PATIENTS WITH 1. PREVIOUS HISTORY OF STROKE 2. MEDICATIONS WHICH CAN INFLUENCE URIC ACID LEVELS 3. KNOWN CASE OF GOUT 4. KIDNEY DISEASES 5. THYROID DISORDERS 6. ON STEROID THERAPY 7. CT SCAN- BLEED IN THE BRAIN 8. HEMATOLOGICAL - BLOOD DISORDERS

Design outcomes

Primary

MeasureTime frame
TO CORRELATE SERUM URIC ACID LEVELS WITH SEVERITY OF STROKE AND OUTCOMETimepoint: 2 YEARS—

Secondary

MeasureTime frame
TO STUDY SERUM URIC ACID LEVEL IN ACUTE PHASE OF ISCHEMIC STROKETimepoint: 2 YEARS—

Countries

India

Contacts

Public ContactDR SAKSHI

KMC Manipal

Manjunath.hande@manipal.edu9972597655

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026